Home / Market News / $KYN

$KYN news and market catalysts

The 3 most recent market catalysts affecting $KYN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

3 catalysts 1 high impact 0 bullish 1 bearish Biotechnology
Nov 17, 2026 Corporate Catalyst Bearish Impact 85
Kyntra Bio Reports Third Quarter 2026 Financial Results and Terminates FG-3246 Phase 2 Trial
Kyntra Bio announced third-quarter 2026 net income of $0.2 million, a significant improvement from a $13.1 million net loss year-over-year, and extended its cash runway into 2028. …
Aug 13, 2026 Corporate Catalyst Neutral Impact 75
Kyntra Bio Q2 EPS $2.96, Sales $(1.474M) Miss $2.007M Estimate
This headline presents a mixed bag for Kyntra Bio. The strong EPS beat suggests efficient operations or one-time gains, which is positive for profitability. However, the significan…
Aug 4, 2026 Corporate Catalyst Neutral Impact 55
Reported Earlier, Kayne Anderson Energy Infrastructure Fund Reports $2.8B Net Assets, $16.49 Net Asset Value Per Share As Of July 31, 2026
The headline reports the net assets and NAV per share for the Kayne Anderson Energy Infrastructure Fund (KYN). This is a standard financial disclosure for a closed-end fund and pro…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.